These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32078349)

  • 21. Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies.
    McCambridge J; Hartwell G
    Drug Alcohol Rev; 2015 Jan; 34(1):58-66. PubMed ID: 24602075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public Health Surveillance Studies of Alcohol Industry Market and Political Strategies: A Systematic Review.
    McCambridge J; Coleman R; McEachern J
    J Stud Alcohol Drugs; 2019 Mar; 80(2):149-157. PubMed ID: 31014459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Public enemy no. 1': Tobacco industry funding for the AIDS response.
    Smith J; Thompson S; Lee K
    SAHARA J; 2016; 13(1):41-52. PubMed ID: 27023371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motives of corporate political donations: industry regulation, subjective judgement and the origins of pragmatic and ideological corporations.
    Harrigan NM
    Br J Sociol; 2017 Dec; 68(4):718-753. PubMed ID: 28832968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review.
    Mialon M; Vandevijvere S; Carriedo-Lutzenkirchen A; Bero L; Gomes F; Petticrew M; McKee M; Stuckler D; Sacks G
    BMJ Open; 2020 Jul; 10(7):e034082. PubMed ID: 32690498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of economic interests on alcohol control policy: a case study from Finland.
    Alavaikko M; Osterberg E
    Addiction; 2000 Dec; 95 Suppl 4():S565-79. PubMed ID: 11218352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Alcohol Industry Submissions against Marketing Regulation.
    Martino FP; Miller PG; Coomber K; Hancock L; Kypri K
    PLoS One; 2017; 12(1):e0170366. PubMed ID: 28118411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research and the alcohol industry.
    Gmel G; Heeb JL; Rehm J
    Addiction; 2003 Dec; 98(12):1773-4; discussion 1774-5. PubMed ID: 14651510
    [No Abstract]   [Full Text] [Related]  

  • 31. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [When is a clinical study non-commercial?].
    Schimetta W; Pölz G; Pölz W; Haring HP; Baumgartner H; Aichner F
    Wien Med Wochenschr; 2005 May; 155(9-10):233-6. PubMed ID: 15999631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining local processes when applying a cumulative impact policy to address harms of alcohol outlet density.
    Grace D; Egan M; Lock K
    Health Place; 2016 Jul; 40():76-82. PubMed ID: 27197092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The handling of evidence in national and local policy making: a case study of alcohol industry actor strategies regarding data on on-premise trading hours and violence in Norway.
    Rossow I; McCambridge J
    BMC Public Health; 2019 Jan; 19(1):44. PubMed ID: 30626353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sponsorship bias in clinical research.
    Lexchin J
    Int J Risk Saf Med; 2012; 24(4):233-42. PubMed ID: 23135338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Be aware of Drinkaware.
    McCambridge J; Kypri K; Miller P; Hawkins B; Hastings G
    Addiction; 2014 Apr; 109(4):519-24. PubMed ID: 24164565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global Fund collusion with liquor giant is a clear conflict of interest.
    Matzopoulos R; Parry CD; Corrigall J; Myers J; Goldstein S; London L
    Bull World Health Organ; 2012 Jan; 90(1):67-9; discussion 70. PubMed ID: 22271967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.
    Fabbri A; Lai A; Grundy Q; Bero LA
    Am J Public Health; 2018 Nov; 108(11):e9-e16. PubMed ID: 30252531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions Between the U.S. National Institute on Alcohol Abuse and Alcoholism and the Alcohol Industry: Evidence From Email Correspondence 2013-2020.
    Mitchell G; McCambridge J
    J Stud Alcohol Drugs; 2023 Jan; 84(1):11-26. PubMed ID: 36799670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conflict of interest and alcohol discourse-a new face but familiar messages.
    Casswell S
    N Z Med J; 2018 Oct; 131(1483):59-62. PubMed ID: 30286066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.